
New Network Integration on Fastex Exchange: Injective (INJ)
Fastex Exchange has announced a new listing for its users. The exchange integrated Injective blockchain and its native coin XTZ on January 14, 2025. The new spot trading pairs INJ/USDT, INJ/USDC are now open for trading on the Fastex Exchange.
-
Deposit for INJ: Opens on on January 14, at 14:00 (UTC+4)
-
Trading for INJ/USDT, INJ/USDC: Begins on January 14, at 14:00 (UTC+4)
-
Withdrawals for INJ: Available from January 14, at 14:00 (UTC+4)
About Injective Blockchain
Injective Blockchain is a high-performance Layer-1 blockchain designed specifically for decentralized finance (DeFi). Built on the Cosmos SDK, it uses the Inter-Blockchain Communication (IBC) protocol to enable smooth cross-chain interactions. Injective offers lightning-fast transaction speeds, negligible fees, and a robust smart contract framework powered by CosmWasm.
Join our community:
Important notice:
In accordance with the applicable provisions of the MiCA regulation that are now in effect, USDT will no longer be available to EEA residents. Henceforth, trading will be restricted to the INJ/USDC pair.
Disclaimer:
Not investment advice. All trading carries risk. Only risk capital you can afford to lose.
Risk warning:
The prices of digital assets are inherently exposed to substantial market risks and unpredictable fluctuations. The worth of your investment can decrease or increase, and it's possible that you won't recover the sum invested. You are the only one accountable for your investment choices, and Fastex disclaims any responsibility for potential losses you might experience. The performance of assets in the past doesn't guarantee similar outcomes in the future. It's advisable to only invest in financial instruments that you comprehend and whose risks you are aware of. Before committing to any investment, reflect on your investment background, financial condition, investment goals, and your capacity to absorb risks, and consider seeking advice from an independent financial consultant. This information should not be interpreted as financial guidance. For additional details, please refer to our Terms of Use and General Risk Disclaimer.